Skip to main content

Leukodystrophy

  • Chapter
  • 1970 Accesses

Abstract

Vanishing leukoencephalopathy is a vacuolating leukoencephalopathy with subcortical cysts. Symptoms develop at 18 months to 5 years of age with slowly progressive cerebellar ataxia, spasticity, variable optic atrophy, late development of bulbar symptoms, and preserved mental capacities. There are adult cases.

This is a preview of subscription content, log in via an institution.

Buying options

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   299.00
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Hardcover Book
USD   379.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

18 Leukodystrophy

  1. Leegwater PA, Pronk JC, van der Knaap MS (2003) Leukoencephalopathy with vanishing white matter: from magnetic resonance imaging pattern to five genes. J Child Neurol 18:639–645.

    Article  PubMed  Google Scholar 

  2. Van der Knaap MS, Leegwater PA, Konst AA, Visser A, Naidu S, Oudejans CB, Schutgens RB, Pronk JC (2002) Mutations in each of the five subunits of translation initiation factor eIF2B can cause leukoencephalopathy with vanishing white matter. Ann Neurol 51:264–270.

    Article  PubMed  Google Scholar 

  3. Van der Knaap MS, Pronk JC, Scheper GC (2006) Vanishing white matter disease. Lancet Neurol 5:413–423.

    Article  PubMed  Google Scholar 

  4. Harding BH, Surtees R (2002) Metabolic and neurodegenerative diseases of childhood. In: Graham DI, Lantos PL (eds) Greenfields’ neuropathology, 7th edn, Vol 1. Arnold, London, pp 494–501.

    Google Scholar 

  5. Suzuki K, Suzuki K (2002) Lysosomal diseases. In: Graham DI, Lantos PL (eds) Greenfields’ neuropathology, 7th edn, Vol 1. Arnold, London, pp 675–682.

    Google Scholar 

  6. Eng LF, Lee YL, Kwan H, Brenner M, Messing A (1998) Astrocytes cultured from transgenic mice carrying the added human glial fibrillary acidic protein gene contain Rosenthal fibers. J Neurosci Res 53:353–360.

    Article  PubMed  CAS  Google Scholar 

  7. Neal JW, Cave EM, Singhrao SK, Cole G, Wallace SJ (1992) Alexander’s disease in infancy and childhood: a report of two cases. Acta Neuropathol (Berl) 84:322–327.

    Article  PubMed  CAS  Google Scholar 

  8. Surendran S, Michals-Mataln K, Quast MJ, Tyring SK, Wei J, Ezell EL, Matalon R (2003) Canavan disease: a monogenic trait with complex interaction. Mol Genet Metab 80:74–80.

    Article  PubMed  CAS  Google Scholar 

  9. Lyon G, Adams LG, Kolodny RD (eds) (1996) Neurology of hereditary metabolic diseases of children, 2nd edn. McGraw-Hill, New York, pp 71–72, 262–263.

    Google Scholar 

  10. Golomb MR, Walsh LE, Carvalho KS, Christensen CK, DeMyer WE (2004) Clinical findings in Pelizaeus-Merzbacher disease. J Child Neurol 19:328–331.

    Article  PubMed  Google Scholar 

  11. Hadson LD (2003) Pelizaeus-Merzbacher disease and spastic paraplegia type 2: two faces of myelin loss from mutations in the same gene. J Child Neurol 18:616–624.

    Article  Google Scholar 

Download references

Rights and permissions

Reprints and permissions

Copyright information

© 2007 Springer

About this chapter

Cite this chapter

(2007). Leukodystrophy. In: Pediatric Neuropathology. Springer, Tokyo. https://doi.org/10.1007/978-4-431-49898-8_18

Download citation

  • DOI: https://doi.org/10.1007/978-4-431-49898-8_18

  • Publisher Name: Springer, Tokyo

  • Print ISBN: 978-4-431-70246-7

  • Online ISBN: 978-4-431-49898-8

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics